About us

Technology

Pipeline

BD & partnership

Investor relations

Cn

Cn

Home

About us

Technology

Pipeline

BD & partnership

Investor relations
Decoding the Language of Cells.
Writing the Future of Cures.

Know us
About Us
Deeply understanding its code and guiding its logic with precision
At Geek Gene, we fuse the “Geek” — an unwavering, detail-obsessed pursuit of scientific truth through single-cell omics — with the “Gene” — a symbol of life’s fundamental program, which we navigate and optimize using non-genetic chemical reprogramming. This unique convergence defines us and the new paradigm we are building.
Our Strategy
Decode
Decode with Single-Cell Fidelity

More
Navigate
Navigate with Chemical Precision

More
Democratize
Democratize through Engineered Simplicity

More
Our Team
The founding team brings together deep academic roots from world-renowned institutions including Harvard University, Peking University, and the University of Tokyo, representing over two decades of pioneering research in chemical reprogramming and single-cell sequencing. This profound scientific legacy is united with a leadership team comprising veteran experts from global pharmaceutical companies, possessing end-to-end drug development expertise from discovery through clinical development

Learn more
Technology
AI-powered Cell Fate
Navigation System
This proprietary platform creates a predictive and programmable framework for precise cellular engineering by integrating single-cell analytics with chemical reprogramming.

News
Share the latest industry
information with you

View all
November 3.2025
Geek Gene Announces IND Clearance for GK01, Advancing the Novel T-Cell Therapy Against Solid Tumor to Registrational Trial
today announced that it has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) for GK01

More
Business Development & Partnership

Co-development of Our Assets

Platform Partnership: Rejuvenating Next Generation Cell Therapies

Explore synergistic combination therapies
janetxuzhang@geekgene.com.cn

To explore potential collaboration, please contact

Co-development of Our Assets
We are now seeking partnership with global biopharmaceutical companies to co develop our assets in overseas markets. A partnership would leverage our deep clinical insights and proprietary manufacturing platform with your global development, regulatory, and commercial expertise—together advancing a potential breakthrough for patients worldwide.
Platform Partnership: Rejuvenating Next Generation Cell Therapies
Beyond our internal pipeline, our AI powered Cell Fate Navigation System is a versatile platform capable of enhancing a wide range of cell based therapeutics. Our technology can be applied to improve the persistence, expansion, and functional potency of third party CAR T, TCR T, or other cell therapy products.
Explore synergistic combination therapies
We welcome collaboration and licensing opportunities to integrate our rejuvenation technology into partners’ existing or emerging cell therapy programs. By combining forces, we can collectively overcome critical limitations in cell durability and efficacy, bringing more effective and accessible treatments to patients faster.